News

Like Parkinson’s disease, ATTR-CM is caused by a buildup of misfolded proteins. In this case, the culprit is transthyretin. Under normal conditions, transthyretin…

A new Mayo Clinic study questions the benefit of implantable cardioverter-defibrillator use to treat patients with transthyretin cardiac amyloidosis.For patients…

JACC: Case Reports is seeking high-impact case reports that advance clinical understanding of cardiac amyloidosis, encouraging submissions that showcase diagnostic…

AbstractBackground: Carpal tunnel syndrome (CTS) has been recognized as a potential early manifestation of systemic amyloidosis; however, its prognostic…

Alzheimers Res Ther. 2026 Feb 14. doi: 10.1186/s13195-026-01974-0. Online ahead of print.ABSTRACTBACKGROUND: Plasma biomarkers have emerged as robust indicators of…

Market OverviewThe Transthyretin amyloid cardiomyopathy (ATTR-CM) was valued at US$ 2.92 Billion n 2023. The global transthyretin amyloid cardiomyopathy (ATTR-CM)…

AbstractIntroduction: Cardiac amyloidosis, primarily comprising transthyretin amyloid cardiomyopathy (ATTR-CM) and light-chain amyloidosis with cardiac involvement…

AbstractGastrointestinal amyloidosis is a rare but often a manifestation of an advanced form of systemic amyloidosis that carries a poor prognosis. Its presentation…

Every day, your heart works tirelessly, pumping blood that delivers the oxygen and nutrients your body needs to function. February is American Heart Month, a…

In this video, Sean Riley from New Hampshire shares his health journey with amyloidosis, a rare genetic condition caused by mutations in certain genes that lead to…